SARAO, Valentina
 Distribuzione geografica
Continente #
NA - Nord America 3.188
EU - Europa 586
AS - Asia 184
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 1
Totale 3.964
Nazione #
US - Stati Uniti d'America 3.170
UA - Ucraina 163
IT - Italia 126
CN - Cina 109
DE - Germania 73
IE - Irlanda 69
TR - Turchia 45
FI - Finlandia 34
BE - Belgio 31
GB - Regno Unito 25
SE - Svezia 22
VN - Vietnam 22
CA - Canada 17
PL - Polonia 12
NL - Olanda 11
AT - Austria 6
IN - India 5
AU - Australia 3
CH - Svizzera 3
EU - Europa 2
FR - Francia 2
RO - Romania 2
BG - Bulgaria 1
BO - Bolivia 1
ES - Italia 1
GL - Groenlandia 1
HU - Ungheria 1
IL - Israele 1
IS - Islanda 1
JP - Giappone 1
LU - Lussemburgo 1
ME - Montenegro 1
RU - Federazione Russa 1
SG - Singapore 1
Totale 3.964
Città #
Fairfield 428
Woodbridge 377
Chandler 360
Ann Arbor 283
Houston 242
Ashburn 229
Seattle 164
Wilmington 157
Cambridge 132
Jacksonville 95
Dearborn 75
Princeton 72
Dublin 69
Beijing 46
Izmir 45
Brussels 31
Udine 30
Ogden 25
San Diego 25
Norwalk 23
Dong Ket 22
New York 20
Des Moines 13
Boardman 12
Warsaw 12
Wuhan 10
Falls Church 9
Redmond 8
Shenzhen 8
Nanjing 7
Chengdu 6
Ottawa 6
Toronto 6
Treviso 6
Vienna 6
Bologna 5
Grafing 5
Guangzhou 5
Rome 5
Chioggia 4
Jinan 4
Kunming 4
Nanchang 4
Amsterdam 3
Andover 3
Camponogara 3
Edinburgh 3
Frankfurt am Main 3
Hefei 3
Helsinki 3
Milan 3
Montreal 3
Turin 3
Hanover 2
Latisana 2
Phoenix 2
Pignone 2
Pomezia 2
Rio Saliceto 2
Stockholm 2
Strigno 2
Venezia 2
Washington 2
Wenzhou 2
Zurich 2
Aiello Del Friuli 1
Arsiero 1
Baotou 1
Brisbane 1
Budapest 1
Buffalo 1
Changsha 1
Chicago 1
Cormeilles-en-Parisis 1
Deventer 1
Edmonton 1
Eindhoven 1
Hangzhou 1
Hebei 1
Indiana 1
Jiaxing 1
Keflavik 1
La Paz 1
Leer 1
London 1
Luxembourg 1
Manchester 1
Mel 1
Melbourne 1
Monmouth Junction 1
Nuuk 1
Palmanova 1
Paris 1
Pisa 1
Podgorica 1
Rockville 1
Ruda 1
Rudiano 1
Shanghai 1
Sofia 1
Totale 3.184
Nome #
Intravitreal aflibercept for choroidal neovascularization due to age-related macular degeneration unresponsive to ranibizumab therapy 152
Fluocinolone acetonide for the treatment of diabetic macular edema 136
A case of CRB1-negative Coats-like retinitis pigmentosa 130
Comparison of short-wavelength blue-light autofluorescence and conventional blue-light autofluorescence in geographic atrophy 128
Optimal Keratoplasty for the Correction of Presbyopia and Hypermetropia 127
Proliferative Diabetic Retinopathy: Treatment Update 125
Online optical coherence tomography during subthreshold laser irradiation 116
Optical coherence tomography angiography findings in diabetic retinopathy 116
One-year results of aflibercept in vascularized pigment epithelium detachment due to neovascular AMD: A prospective study 116
Neovascular age-related macular degeneration 115
Intravitreal bevacizumab for choroidal neovascularization due to pathologic myopia: long-term outcomes 113
Bevacizumab and triamcinolone acetonide for choroidal neovascularization due to age-related macular degeneration unresponsive to antivascular endothelial growth factors 107
Update on combination therapy in wet age-related macular degeneration 105
Dexamethasone implant with fixed or individualized regimen in the treatment of diabetic macular oedema: Six-month outcomes of the UDBASA study 105
Early Effects of Dexamethasone Implant on Macular Morphology and Visual Function in Patients with Diabetic Macular Edema 103
Dexamethasone implant in diabetic macular edema in real-life situations 102
Drug safety evaluation of intravitreal triamcinolone acetonide 100
Author’s response 100
New advances in retina: A report from the International Symposium on Ocular Pharmacology and Therapeutics meeting 96
Pharmacotherapy for treatment of retinal vein occlusion. 86
Triamcinolone acetonide for the treatment of diabetic macular oedema 84
Safety of 6000 intravitreal dexamethasone implants 84
Early Response to Intravitreal Dexamethasone Implant Therapy in Diabetic Macular Edema May Predict Visual Outcome 82
Pharmacotherapeutic management of macular edema in diabetic subjects undergoing cataract surgery 81
Intravitreal steroids for the treatment of retinal diseases. 77
A comparison between a white LED confocal imaging system and a conventional flash fundus camera using chromaticity analysis 75
TWELVE-MONTH OUTCOMES OF INTRAVITREAL AFLIBERCEPT FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Fixed Versus As-needed Dosing 73
Green emission fluorophores in eyes with atrophic age-related macular degeneration: A colour fundus autofluorescence pilot study 68
A Propensity-Score Matching Comparison between 27-Gauge and 25-Gauge Vitrectomy Systems for the Repair of Primary Rhegmatogenous Retinal Detachment 67
Regression of diabetic macular edema after subcutaneous exenatide. 66
Steroids in a Combination Strategy 64
Dexamethasone Implant Produces Better Outcomes than Oral Acetazolamide in Patients with Cystoid Macular Edema Secondary to Retinitis Pigmentosa 64
Infection control measures in ophthalmology during the COVID-19 outbreak: A narrative review from an early experience in Italy 62
Macular pucker 55
Impact on quality of life 47
Dexamethasone implant with fixed or individualized regimen in the treatment of diabetic macular edema: the UDBASA study 43
Correction to: Fundamental principles of an effective diabetic retinopathy screening program (Acta Diabetologica, (2020), 57, 7, (785-798), 10.1007/s00592-020-01506-8) 43
Ocular Findings in {COVID}-19 Patients: A Review of Direct Manifestations and Indirect Effects on the Eye 41
Edema maculare post occlusione venosa 32
Does lens influence green component in short 450 nm color autofluorescence? A cross-sectional study in heathy Caucasian population 32
Automated diabetic retinopathy detection with two different retinal imaging devices using artificial intelligence: a comparison study 32
Intravitreal Aflibercept for Choroidal Neovascularization Due to Age-Related Macular Degeneration Unresponsive to Ranibizumab Therapy 31
Combination Therapy for Choroidal Neovascularization Due to Age-Related Macular Degeneration Unresponsive to Anti-VEGF Monotherapy. Intravitreal Bevacizumab and Triamcinolone Acetonide 31
Intravitreal Bevacizumab for Choroidal Neovascularization due to Pathological Myopia: Long-term Outcomes 31
Choroidal Thickness Influences Green Emission Autofluorescence Component Intensity in Eyes with Geographic Atrophy Due to Age-Related Macular degeneration: A Color Fundus Autofluorescence Study 29
Choriocapillaris and outer choroid blood flow in acute central serous chorioretinopathy: a swept source OCT angiography study 29
Present Status of Laser Therapy: Role of Subthreshold Laser 28
Anti-VEGF Drugs Dynamics: Relevance for Clinical Practice 28
Screening performance of an automated image analysis software for the detection of diabetic retinopathy using a conventional fundus photography or a confocal white LED device: a comparison study 26
Ranibizumab in neovascular age-related macular degeneration: an as-needed treatment regimen with bimonthly evaluation 26
INTRAVITREAL DEXAMETHASONE IMPLANT FOR THE TREATMENT OF DIFFUSE DIABETIC MACULAR EDEMA UNRESPONSIVE TO ANTI-VEGF THERAPY 25
Twelve months outcomes of Intravitreal aflibercept for neovascular age-related macular degeneration. Fixed versus as needed dosing 24
Does the presence of vitreo-macular adhesion influence the outcome of antivascular endothelial growth factor therapy in patients with neovascular agerelated macular degeneration? Systematic review and meta-analysis 24
Chromaticity analysis comparing a white light confocal imaging device versus a flash fundus camera 23
Long-term Effect of Intravitreal Bevacizumab on Chorioretinal Atrophy Progression in Myopic Choroidal Neovascularization 23
One-year efficacy of anti-vascular endothelial growth factor agents in patients with neovascular age-related macular degeneration: a meta-analysis and meta-regression 22
Scleral fixation of a single-piece foldable acrylic IOL through a 1.80 mm corneal incision 20
OCT angiography in chronic central serous chorioretinopathy 20
Effect of COVID-19-related lockdown on ophthalmic practice in Italy: A report from 39 institutional centers 20
Response to:Letter to the editor: Infection control measures in ophthalmology during the COVID-19 outbreak: A narrative review from an early experience in Italy 16
Vitrectomized vs non-vitrectomized eyes in DEX implant treatment for DMO—Is there any difference? the VITDEX study 15
Fundamental principles of an effective diabetic retinopathy screening program 14
Macular Holes 14
Twelve-month treatment with intravitreal dexamethasone implant for diabetic macular edema 14
One-year outcomes of dexamethasone implant versus oral acetazolamide for the treatment of cystoid macular edema in patients with retinitis pigmentosa 13
Managing diabetic macular edema in clinical practice: systematic review and meta-analysis of current strategies and treatment options 13
State-of-the art pharmacotherapy for non-neovascular age-related macular degeneration 11
Long-term outcomes after intravitreal dexamethasone treatment in steroid responders 11
Lens fogging comment on “Infection control measures in ophthalmology during the COVID-19 outbreak: A narrative review from an early experience in Italy” 11
Response to: Should we establish a new normality for ophthalmic training in the COVID-19 pandemic? 10
Managing Neovascular Age-Related Macular Degeneration in Clinical Practice: Systematic Review, Meta-Analysis, and Meta-Regression 9
Surgical Management for Diabetic Macular Edema 8
Stem cell therapy in retinal diseases: current evidence 8
Response to: New norms in ophthalmic surgery during the COVID-19 pandemic: A narrative review from a Malaysia tertiary eye care center 8
The Present and Future of Optic Pathway Glioma Therapy 5
The ideal intravitreal injection setting: office, ambulatory surgery room or operating theatre? A narrative review and international survey 5
Behind the mask: a critical perspective on the ethical, moral, and legal implications of AI in ophthalmology 5
Explainable artificial intelligence model for the detection of geographic atrophy using colour retinal photographs 4
Update on coronavirus disease 2019: Ophthalmic Manifestations and Adverse Reactions to Vaccination 3
Totale 4.207
Categoria #
all - tutte 14.913
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.913


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019382 0 0 0 0 0 0 0 0 0 61 196 125
2019/20201.113 62 42 43 161 85 162 102 122 97 79 28 130
2020/2021675 33 70 68 98 36 56 28 70 84 27 52 53
2021/2022451 22 26 9 7 14 22 35 23 18 84 101 90
2022/2023770 96 51 7 121 82 179 6 71 98 8 31 20
2023/2024227 50 17 8 10 38 30 11 26 37 0 0 0
Totale 4.207